HealthCare Global Enterprises Limited (NSE:HCG)
India · Delayed Price · Currency is INR 655.30
+28.30 (4.51%)
May 22, 2026, 3:29 PM IST
NSE:HCG Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 25,384 | 22,181 | 19,079 | 16,914 | 13,948 |
Other Revenue | 319.7 | 47.14 | 42.48 | 30.33 | 30.05 |
| 25,704 | 22,229 | 19,121 | 16,944 | 13,978 | |
Revenue Growth (YoY) | 15.63% | 16.25% | 12.85% | 21.22% | 37.92% |
Cost of Revenue | 16,200 | 10,319 | 8,646 | 7,747 | 6,457 |
Gross Profit | 9,504 | 11,910 | 10,475 | 9,198 | 7,521 |
Selling, General & Admin | - | 732.02 | 619.64 | 448.05 | 273.86 |
Other Operating Expenses | 4,597 | 7,188 | 6,553 | 5,442 | 4,869 |
Operating Expenses | 7,038 | 10,130 | 8,921 | 7,842 | 6,725 |
Operating Income | 2,466 | 1,780 | 1,555 | 1,355 | 795.46 |
Interest Expense | -1,766 | -1,443 | -979.33 | -904.6 | -831.05 |
Interest & Investment Income | - | 158.82 | 126.97 | 118.1 | 115.61 |
Earnings From Equity Investments | 14.6 | 7.71 | 3.88 | -0.18 | -14.25 |
Currency Exchange Gain (Loss) | - | -2.94 | 0.65 | -17.56 | -0.29 |
Other Non Operating Income (Expenses) | - | 68.37 | -77.2 | -95.47 | -128.67 |
EBT Excluding Unusual Items | 715 | 568.47 | 629.83 | 455.54 | -63.19 |
Merger & Restructuring Charges | - | - | - | - | -5.5 |
Gain (Loss) on Sale of Investments | - | 1.57 | 2.17 | 0.35 | 1.24 |
Gain (Loss) on Sale of Assets | - | -10.64 | -17.74 | -13.22 | -6.43 |
Asset Writedown | - | - | - | - | -467.4 |
Other Unusual Items | -445.8 | 10.24 | 63.03 | 6.13 | 1,419 |
Pretax Income | 269.2 | 569.64 | 677.29 | 448.8 | 877.72 |
Income Tax Expense | 41.4 | 81.3 | 263.95 | 272.5 | 488.47 |
Earnings From Continuing Operations | 227.8 | 488.34 | 413.34 | 176.3 | 389.25 |
Minority Interest in Earnings | -90.2 | -44.24 | 68.21 | 117.19 | 148.08 |
Net Income | 137.6 | 444.1 | 481.55 | 293.49 | 537.33 |
Net Income to Common | 137.6 | 444.1 | 481.55 | 293.49 | 537.33 |
Net Income Growth | -69.02% | -7.78% | 64.08% | -45.38% | - |
Shares Outstanding (Basic) | 142 | 139 | 139 | 139 | 130 |
Shares Outstanding (Diluted) | 143 | 141 | 140 | 140 | 135 |
Shares Change (YoY) | 1.30% | 0.77% | 0.50% | 3.35% | 18.95% |
EPS (Basic) | 0.97 | 3.19 | 3.46 | 2.11 | 4.14 |
EPS (Diluted) | 0.96 | 3.14 | 3.43 | 2.10 | 3.97 |
EPS Growth | -69.43% | -8.46% | 63.33% | -47.10% | - |
Free Cash Flow | 550 | 1,082 | 988.99 | 1,184 | 1,489 |
Free Cash Flow Per Share | 3.84 | 7.65 | 7.04 | 8.47 | 11.01 |
Gross Margin | 36.98% | 53.58% | 54.78% | 54.28% | 53.80% |
Operating Margin | 9.59% | 8.01% | 8.13% | 8.00% | 5.69% |
Profit Margin | 0.53% | 2.00% | 2.52% | 1.73% | 3.84% |
Free Cash Flow Margin | 2.14% | 4.87% | 5.17% | 6.98% | 10.65% |
EBITDA | 4,908 | 3,129 | 2,671 | 2,372 | 1,784 |
EBITDA Margin | 19.09% | 14.08% | 13.97% | 14.00% | 12.76% |
D&A For EBITDA | 2,442 | 1,350 | 1,116 | 1,017 | 988.67 |
EBIT | 2,466 | 1,780 | 1,555 | 1,355 | 795.46 |
EBIT Margin | 9.59% | 8.01% | 8.13% | 8.00% | 5.69% |
Effective Tax Rate | 15.38% | 14.27% | 38.97% | 60.72% | 55.65% |
Revenue as Reported | 25,704 | 22,577 | 19,291 | 17,076 | 14,105 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.